Yossi Maimon
2017 - Protalix BioTherapeutics
In 2017, Yossi Maimon earned a total compensation of $759K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 71% increase compared to previous year.
Compensation breakdown
| Bonus | $363,647 |
|---|---|
| Option Awards | $37,686 |
| Salary | $282,197 |
| Other | $75,448 |
| Total | $758,978 |
Maimon received $363.6K in bonus, accounting for 48% of the total pay in 2017.
Maimon also received $37.7K in option awards, $282.2K in salary and $75.4K in other compensation.
Rankings
In 2017, Yossi Maimon's compensation ranked 10,242nd out of 14,666 executives tracked by ExecPay. In other words, Maimon earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,242 out of 14,666 | 30th |
Division Manufacturing | 3,969 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,395 out of 2,075 | 33rd |
Industry group Drugs | 1,133 out of 1,731 | 35th |
Industry Biological Products, Except Diagnostic Substances | 203 out of 313 | 35th |
Source: SEC filing on March 6, 2018.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2017.
2017
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2017
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2017
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2017
Tzvi Palash
Protalix BioTherapeutics